サメット・ヤルディムジ教授（医学博士）は、MDアンダーソンがんセンターで腹腔鏡手術およびがん手術の訓練を受け、最先端の技術を診療に取り入れています。
ムスタファ・ソラク医師は消化器がんを専門とし、ハジェテペ大学がん研究所およびMDアンダーソンがんセンターで研修を受けました。
ハビエル・センテノ・フォルニエス医師は、テノン医療センターの結腸直腸および消化器外科医です。米国ロチェスターのメイヨークリニックで専門的なトレーニングを修了しました。センテノ医師は、痔、ヘルニア、消化器腫瘍の治療に注力しています。テノンでの彼の診療は、クリニックのJCIおよびEFQM品質認定によって裏付けられています。
Lana Bijelic医師は腹膜播種を専門とし、ワシントン・ホスピタル・センターにてPaul Sugarbaker教授のもとで研修を受けました。
トルコで初めてDa Vinciロボット支援システムを使用した一般外科手術を実施。ディベコグル医師は、高度な腹腔鏡手術およびロボット手術を専門としています。
タフシン・オザトリ准教授は、イスティニエ・リヴ大学病院にて乳がん、肺がん、消化器がんを専門としています。
セリン・カパン教授は、イスティニエ大学リヴ病院トプカプにて、_doctor_10984_年以上の外科的経験を持ち、高度な腹腔鏡下手術を専門としています。
アレムダル医師は、メディカルパーク・アンタルヤ病院コンプレックスにて腹腔鏡下直腸間膜切除術を専門としており、腫瘍内科における広範なトレーニングを受けています。
アウアラ・ヒューバート医師は、36 年の経験を持つ腫瘍内科および放射線治療の専門医であり、ハダッサ医療センターの消化器がんセンターを率いています。
Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.
1980–1985: Completed doctoral studies at Nagasaki University, Japan
1968–present: Department of Radiology, Chinese PLA General Hospital
1988: Third Prize of the Military Science and Technology Progress Award
1989–present: Member of Radiological Society of North America(RSNA)
1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA
1991: Second Prize of the Military Science and Technology Progress Award
1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology
1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
1993: Granted the Lifetime Special Government Allowance of the State Council
1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology
1994: Third Prize of the Military Science and Technology Progress Award
1997: Second Prize of the Military Science and Technology Progress Award
1997–2009: Standing Member of Chinese Society of Radiology
1999: Third Prize of the Military Science and Technology Progress Award
1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology
2002: Second Prize of the Military Science and Technology Progress Award
2005: Third Prize of the Military Science and Technology Progress Award
Member of Radiological Society of North America(RSNA)
Standing Member of Chinese Society of Radiology
Group Leader of the Group of Intervention of Chinese Journal of Radiology
Deputy Director Member of Chinese Society of Interventional Oncology
Director Member of Beijing Medical Association Society of Interventional Radiology
Deputy Chief Editor of Chinese Journal of Medical Image Technology
Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army
Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
Awarded the Special Government Allowance of the State Council
Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.
Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”
Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.
In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.
Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.
In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.
Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.
From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.
Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.
1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.
Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.
2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.
Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.
3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.
Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.
4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.
Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.
5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.
Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.
6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.
Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.
7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.
Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.
8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.
Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.
1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.
2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.
3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.
1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.
2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.
3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.
4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.
准教授のCevper Ersozは、Medipol Acibadem地区病院にてロボット支援および腹腔鏡下泌尿器科手術を専門としています。
パヴェウ・グロホヴィッチ医師（MD, PhD）は、約40年の経験を持つ肛門科医です。聖エリザベス病院のワルシャワ肛門科センターに勤務しています。痔、肛門瘻、肛門周囲膿瘍、肛門裂傷、便失禁、毛巣嚢胞の治療を行っています。また、大腸内視鏡検査や大腸ポリープ切除術も実施しています。
1979年から2016年まで、ポーランドで唯一の専門センターであるソレツ病院の肛門科ユニットに勤務していました。2016年からは聖エリザベス病院のワルシャワ肛門科センターに勤務しています。そこで新しい治療法の開発と導入を行い、診断、リハビリテーション、研究、教育活動を行っています。同センターはポーランド大腸肛門病クラブの本部でもあります。
学術・研究職：ポーランド科学アカデミー実験臨床医学研究所（1979–1997年）。ミュンヘン大学DAAD奨学生（1983–1984年）。オーストラリア、ニューカッスル大学ジョン・ハンター病院（1989–1996年）。同病院では移植研究ユニットのディレクターおよび主任科学官を務めました（1991–1996年）。
アブドラ・サキン教授（Prof. Dr. Abdullah Sakin）は、腫瘍内科の教授です。肺がん、乳がん、消化器がん、泌尿器がん、婦人科がん、頭頸部がん、悪性黒色腫（メラノーマ）などの固形腫瘍を専門としています。
科学的根拠に基づいた個別化医療を提供しています。治療法には、化学療法、分子標的療法、免疫療法、ホルモン療法、精密腫瘍学（プレシジョン・オンコロジー）が含まれます。200本以上の科学論文を執筆しており、国際的な臨床研究にも積極的に参加しています。これらの活動は、患者中心のがん医療の発展に寄与しています。
Gül Alço教授は、約27年の経験を持つ放射線腫瘍医です。乳がん、肺がん、前立腺がん、消化器がん、婦人科がん、中枢神経系腫瘍、頭頸部がん、軟部組織腫瘍、骨腫瘍の放射線治療を行っています。
専門分野は、適応放射線治療とラジオサージャリー（放射線外科）です。高度な放射線技術を駆使し、患者中心の多職種連携環境において、個別化された科学的根拠に基づくケアを提供しています。
プシェミスワフ・チェシェルスキ医師は一般外科医です。2008年に専門医課程を修了しました。1999年にワルシャワ医科大学を卒業しました。2010年に医学博士号を取得しました。彼の論文は、大腸がんのリスクが高い患者における大腸疾患を診断するための臨床検査および直腸鏡検査を評価したものです。
彼の肛門科および大腸外科のトレーニングには、正式なコースやフェローシップが含まれます。2021年と2022年にヴェルチェッリの聖ロタ病院で、2016年にケルンで肛門科コースを修了しました。2014年にウィーン医科大学、2015年にマクデブルク大学で一般外科の臨床フェローシップを務めました。2005年から2013年まで、ワルシャワのソレック病院肛門科で複数のフェローシップを経験しました。ポズナンとウッチで開催された高度な大腸外科ワークショップに参加しました。また、ロンドンのセントマークス病院で「大腸疾患の最前線」や「高度大腸外科ワークショップ」などのコースも修了しています。
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 23年の経験 | 高度な腹腔鏡手術 | MDアンダーソンがんセンターで訓練を受け、最先端の腹腔鏡技術を導入。資格取得時にトルコ最年少の消化器外科医として表彰された。 | トルコ | お問い合わせください | |
| #2 | 20年の経験 | 消化器がん | 消化器がんを専門とし、ハジェテペ大学がん研究所およびMDアンダーソンがんセンターでの研修経験を持つ。多岐にわたるがんの複雑な症例に対応。 | トルコ | から $100 | |
| #3 | 28年の経験 | 腹膜播種 | Paul Sugarbaker教授のもとで研修を受けた腹膜播種の専門家。米国外科専門医委員会認定医であり、複数の外科医学会の会員。 | スペイン | お問い合わせください | |
| #4 | 35年の経験 | 高度な腹腔鏡手術 | トルコにおけるロボット手術のパイオニアであり、初のDa Vinci手術を実施。低侵襲の大腸およびGERD手術を専門とする。権威ある外科医学会の会員。 | トルコ | お問い合わせください | |
| #5 | 2016年の経験 | 消化器がん | 消化器がんを専門とし、豊富な病院勤務経験を持つ。2016年より准教授。 | トルコ | お問い合わせください | |
| #6 | 31年の経験 | 高度な腹腔鏡下手術 | 低侵襲手術を専門とし、腹腔鏡下手術に関する多数の論文を発表。一般外科教授であり、主要な外科関連学会の会員。 | トルコ | お問い合わせください | |
| #7 | 20年の経験 | 腹腔鏡下直腸間膜切除術 | 直腸間膜切除術の低侵襲技術を専門とする。アクデニズ大学で研修を受けた腫瘍内科専門医。 | トルコ | お問い合わせください | |
| #8 | 36年の経験 | 消化器がんの症例 | ハダッサの消化器がんセンターを率い、腫瘍学で33年の経験を持つ。認定医であり、イスラエルの主要ながん関連学会で活動中。 | イスラエル | お問い合わせください | |
| #9 | 20年の経験 | ロボット支援および腹腔鏡下泌尿器科手術 | 豊富な学術的背景を持ち、低侵襲手術を専門としています。欧州泌尿器科学会会員であり、130以上の出版物があります。 | トルコ | お問い合わせください |